Garry Handelman to Prospective Studies
This is a "connection" page, showing publications Garry Handelman has written about Prospective Studies.
Connection Strength
0.113
-
Sirover WD, Liu Y, Logan A, Hunter K, Benz RL, Prasad D, Avila J, Venkatchalam T, Weisberg LS, Handelman GJ. Plasma ascorbic acid concentrations in prevalent patients with end-stage renal disease on hemodialysis. J Ren Nutr. 2015 May; 25(3):292-300.
Score: 0.070
-
Raimann JG, Abbas SR, Liu L, Larive B, Beck G, Kotanko P, Levin NW, Handelman G. The effect of increased frequency of hemodialysis on vitamin C concentrations: an ancillary study of the randomized Frequent Hemodialysis Network (FHN) daily trial. BMC Nephrol. 2019 05 17; 20(1):179.
Score: 0.024
-
Liu Y, Weisberg LS, Langman CB, Logan A, Hunter K, Prasad D, Avila J, Venkatchalam T, Berns JS, Handelman GJ, Sirover WD. Plasma oxalate levels in prevalent hemodialysis patients and potential implications for ascorbic acid supplementation. Clin Biochem. 2016 Oct; 49(15):1133-1139.
Score: 0.019